Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356986 · ClinicalTrials.gov registry record
Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
A clinical trial, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- 50
- Enrollment target
NCT07356986 is a clinical trial that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 50 participants.
The verdict
NCT07356986 has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their most recent pregnancy.
Interventions
- DEVICE Dexcom Stelo real-time Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07356986
The ClinicalTrials.gov registry entry for NCT07356986 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Stelo real-time Continuous Glucose Monitor is the first listed.
NCT07356986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07356986 about?
NCT07356986 is a clinical study titled "Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness". The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their m...
What is the current status of trial NCT07356986?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07356986?
The interventions under investigation include: Dexcom Stelo real-time Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT07356986?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.